Global Nuclear Receptor ROR-Gamma Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 10, 2020  |  166 PAGES  |  REPORT CODE: CMM341303
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Nuclear Receptor ROR-Gamma is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period. The research provides insights for the global Nuclear Receptor ROR-Gamma market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Nuclear Receptor ROR-Gamma industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Nuclear Receptor ROR-Gamma Market Segmentations:

By Players:

  • 4SC AG

  • Advinus Therapeutics Ltd

  • Arrien Pharmaceuticals, LLC

  • Aurigene Discovery Technologies Limited

  • Biogen, Inc

  • Brickell Biotech, Inc

  • Bristol-Myers Squibb Company

  • Celgene Corporation

  • Genentech, Inc

  • Genfit SA

  • GlaxoSmithKline Plc

  • Hanmi Pharmaceuticals, Co Ltd

  • Karo Bio AB

  • Lead Pharma Holding BV

  • Nuevolution AB

  • Phenex Pharmaceuticals AG

  • Reata Pharmaceuticals, Inc

  • Teijin Pharma Limited

  • Visionary Pharmaceuticals, Inc

  • Vitae Pharmaceuticals, Inc

By Types:

  • VPR-66

  • INV-17

  • GSK-2981278

  • BBI-6000

  • Others

By End-User:

  • Hospital

  • Clinic

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Receptor ROR-Gamma Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of VPR-66 from 2014 to 2026

    • 1.3.2 Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of INV-17 from 2014 to 2026

    • 1.3.3 Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of GSK-2981278 from 2014 to 2026

    • 1.3.4 Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of BBI-6000 from 2014 to 2026

    • 1.3.5 Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.3 Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Nuclear Receptor ROR-Gamma Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Nuclear Receptor ROR-Gamma by Major Types

    • 3.4.1 Nuclear Receptor ROR-Gamma Market Size and Growth Rate of VPR-66

    • 3.4.2 Nuclear Receptor ROR-Gamma Market Size and Growth Rate of INV-17

    • 3.4.3 Nuclear Receptor ROR-Gamma Market Size and Growth Rate of GSK-2981278

    • 3.4.4 Nuclear Receptor ROR-Gamma Market Size and Growth Rate of BBI-6000

    • 3.4.5 Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Others

4 Segmentation of Nuclear Receptor ROR-Gamma Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Nuclear Receptor ROR-Gamma by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Nuclear Receptor ROR-Gamma in Hospital

    • 4.4.2 Market Size and Growth Rate of Nuclear Receptor ROR-Gamma in Clinic

    • 4.4.3 Market Size and Growth Rate of Nuclear Receptor ROR-Gamma in Others

5 Market Analysis by Major Regions

  • 5.1 Global Nuclear Receptor ROR-Gamma Production Analysis by Major Regions

  • 5.2 Global Nuclear Receptor ROR-Gamma Consumption Analysis by Major Regions

  • 5.3 Global Nuclear Receptor ROR-Gamma Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Nuclear Receptor ROR-Gamma Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Nuclear Receptor ROR-Gamma Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Nuclear Receptor ROR-Gamma Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Production, Import, Consumption and Export Analysis

6 Product Commodity of Nuclear Receptor ROR-Gamma Market in Major Countries

  • 6.1 Top 5 Export Countries in Nuclear Receptor ROR-Gamma market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Nuclear Receptor ROR-Gamma market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Nuclear Receptor ROR-Gamma market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Nuclear Receptor ROR-Gamma market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Nuclear Receptor ROR-Gamma market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Nuclear Receptor ROR-Gamma market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Nuclear Receptor ROR-Gamma Landscape Analysis

  • 7.1 North America Nuclear Receptor ROR-Gamma Landscape Analysis by Major Types

  • 7.2 North America Nuclear Receptor ROR-Gamma Landscape Analysis by Major End-Users

  • 7.3 North America Nuclear Receptor ROR-Gamma Landscape Analysis by Major Countries

    • 7.3.1 United States Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 7.3.2 Canada Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 7.3.3 Mexico Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

8 Europe Nuclear Receptor ROR-Gamma Landscape Analysis

  • 8.1 Europe Nuclear Receptor ROR-Gamma Landscape Analysis by Major Types

  • 8.2 Europe Nuclear Receptor ROR-Gamma Landscape Analysis by Major End-Users

  • 8.3 Europe Nuclear Receptor ROR-Gamma Landscape Analysis by Major Countries

    • 8.3.1 Germany Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 8.3.2 UK Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 8.3.3 France Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 8.3.4 Italy Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 8.3.6 Spain Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 8.3.7 Belgium Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 8.3.8 Poland Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 8.3.9 Russia Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 8.3.10 Turkey Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

9 Asia Pacific Nuclear Receptor ROR-Gamma Landscape Analysis

  • 9.1 Asia Pacific Nuclear Receptor ROR-Gamma Landscape Analysis by Major Types

  • 9.2 Asia Pacific Nuclear Receptor ROR-Gamma Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Nuclear Receptor ROR-Gamma Landscape Analysis by Major Countries

    • 9.3.1 China Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 9.3.2 Japan Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 9.3.4 India Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 9.3.6 South Korea Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

10 Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 10.3.2 Brazil Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 10.3.3 Nigeria Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

    • 10.3.4 South Africa Nuclear Receptor ROR-Gamma Market Volume and Growth Rate 

    • 10.3.5 Argentina Nuclear Receptor ROR-Gamma Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 4SC AG

    • 11.1.1 4SC AG Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Advinus Therapeutics Ltd

    • 11.2.1 Advinus Therapeutics Ltd Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Arrien Pharmaceuticals, LLC

    • 11.3.1 Arrien Pharmaceuticals, LLC Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Aurigene Discovery Technologies Limited

    • 11.4.1 Aurigene Discovery Technologies Limited Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Biogen, Inc

    • 11.5.1 Biogen, Inc Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Brickell Biotech, Inc

    • 11.6.1 Brickell Biotech, Inc Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Bristol-Myers Squibb Company

    • 11.7.1 Bristol-Myers Squibb Company Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Celgene Corporation

    • 11.8.1 Celgene Corporation Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Genentech, Inc

    • 11.9.1 Genentech, Inc Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Genfit SA

    • 11.10.1 Genfit SA Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 GlaxoSmithKline Plc

    • 11.11.1 GlaxoSmithKline Plc Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Hanmi Pharmaceuticals, Co Ltd

    • 11.12.1 Hanmi Pharmaceuticals, Co Ltd Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Karo Bio AB

    • 11.13.1 Karo Bio AB Company Profile and Recent Development

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Lead Pharma Holding BV

    • 11.14.1 Lead Pharma Holding BV Company Profile and Recent Development

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Nuevolution AB

    • 11.15.1 Nuevolution AB Company Profile and Recent Development

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Phenex Pharmaceuticals AG

    • 11.16.1 Phenex Pharmaceuticals AG Company Profile and Recent Development

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 Reata Pharmaceuticals, Inc

    • 11.17.1 Reata Pharmaceuticals, Inc Company Profile and Recent Development

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

  • 11.18 Teijin Pharma Limited

    • 11.18.1 Teijin Pharma Limited Company Profile and Recent Development

    • 11.18.2 Market Performance

    • 11.18.3 Product and Service Introduction

  • 11.19 Visionary Pharmaceuticals, Inc

    • 11.19.1 Visionary Pharmaceuticals, Inc Company Profile and Recent Development

    • 11.19.2 Market Performance

    • 11.19.3 Product and Service Introduction

  • 11.20 Vitae Pharmaceuticals, Inc

    • 11.20.1 Vitae Pharmaceuticals, Inc Company Profile and Recent Development

    • 11.20.2 Market Performance

    • 11.20.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 77 Figures and 134 Tables)

  • Figure Product Picture

  • Figure Nuclear Receptor ROR-Gamma Market Size and Growth Rate of VPR-66 from 2014 to 2026

  • Figure Nuclear Receptor ROR-Gamma Market Size and Growth Rate of INV-17 from 2014 to 2026

  • Figure Nuclear Receptor ROR-Gamma Market Size and Growth Rate of GSK-2981278 from 2014 to 2026

  • Figure Nuclear Receptor ROR-Gamma Market Size and Growth Rate of BBI-6000 from 2014 to 2026

  • Figure Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Hospital from 2014 to 2026

  • Figure Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Clinic from 2014 to 2026

  • Figure Global Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Nuclear Receptor ROR-Gamma Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Nuclear Receptor ROR-Gamma Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Nuclear Receptor ROR-Gamma

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Nuclear Receptor ROR-Gamma by Different Types from 2014 to 2026

  • Table Consumption Share of Nuclear Receptor ROR-Gamma by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of VPR-66

  • Figure Market Size and Growth Rate of INV-17

  • Figure Market Size and Growth Rate of GSK-2981278

  • Figure Market Size and Growth Rate of BBI-6000

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Nuclear Receptor ROR-Gamma by Different End-Users from 2014 to 2026

  • Table Consumption Share of Nuclear Receptor ROR-Gamma by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital

  • Figure Market Size and Growth Rate of Clinic

  • Figure Market Size and Growth Rate of Others

  • Table Global Nuclear Receptor ROR-Gamma Production by Major Regions

  • Table Global Nuclear Receptor ROR-Gamma Production Share by Major Regions

  • Figure Global Nuclear Receptor ROR-Gamma Production Share by Major Regions in 2014

  • Figure Global Nuclear Receptor ROR-Gamma Production Share by Major Regions in 2018

  • Figure Global Nuclear Receptor ROR-Gamma Production Share by Major Regions in 2026

  • Table Global Nuclear Receptor ROR-Gamma Consumption by Major Regions

  • Table Global Nuclear Receptor ROR-Gamma Consumption Share by Major Regions

  • Figure Global Nuclear Receptor ROR-Gamma Consumption Share by Major Regions in 2014

  • Figure Global Nuclear Receptor ROR-Gamma Consumption Share by Major Regions in 2018

  • Figure Global Nuclear Receptor ROR-Gamma Consumption Share by Major Regions in 2026

  • Table North America Nuclear Receptor ROR-Gamma Production, Import, Consumption and Export Analysis

  • Table Europe Nuclear Receptor ROR-Gamma Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Nuclear Receptor ROR-Gamma Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Nuclear Receptor ROR-Gamma market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Nuclear Receptor ROR-Gamma market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Nuclear Receptor ROR-Gamma market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Nuclear Receptor ROR-Gamma market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Nuclear Receptor ROR-Gamma Consumption by Types from 2014 to 2026

  • Table North America Nuclear Receptor ROR-Gamma Consumption Share by Types from 2014 to 2026

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Share by Types in 2014

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Share by Types in 2018

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Share by Types in 2026

  • Table North America Nuclear Receptor ROR-Gamma Consumption by End-Users from 2014 to 2026

  • Table North America Nuclear Receptor ROR-Gamma Consumption Share by End-Users from 2014 to 2026

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2014

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2018

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2026

  • Table North America Nuclear Receptor ROR-Gamma Consumption by Major Countries from 2014 to 2026

  • Table North America Nuclear Receptor ROR-Gamma Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2014

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2018

  • Figure North America Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2026

  • Figure United States Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Nuclear Receptor ROR-Gamma Consumption by Types from 2014 to 2026

  • Table Europe Nuclear Receptor ROR-Gamma Consumption Share by Types from 2014 to 2026

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Share by Types in 2014

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Share by Types in 2018

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Share by Types in 2026

  • Table Europe Nuclear Receptor ROR-Gamma Consumption by End-Users from 2014 to 2026

  • Table Europe Nuclear Receptor ROR-Gamma Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2014

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2018

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2026

  • Table Europe Nuclear Receptor ROR-Gamma Consumption by Major Countries from 2014 to 2026

  • Table Europe Nuclear Receptor ROR-Gamma Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2014

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2018

  • Figure Europe Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2026

  • Figure Germany Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure France Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Nuclear Receptor ROR-Gamma Consumption by Types from 2014 to 2026

  • Table Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by Types in 2014

  • Figure Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by Types in 2018

  • Figure Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by Types in 2026

  • Table Asia Pacific Nuclear Receptor ROR-Gamma Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2014

  • Figure Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2018

  • Figure Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2026

  • Table Asia Pacific Nuclear Receptor ROR-Gamma Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2026

  • Figure China Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandNuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure India Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Nuclear Receptor ROR-Gamma Consumption Share by Major Countries in 2026

  • Figure GCC Countries Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Nuclear Receptor ROR-Gamma Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of 4SC AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 4SC AG

  • Figure Sales and Growth Rate Analysis of 4SC AG

  • Figure Revenue and Market Share Analysis of 4SC AG

  • Table Product and Service Introduction of 4SC AG

  • Table Company Profile and Development Status of Advinus Therapeutics Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advinus Therapeutics Ltd

  • Figure Sales and Growth Rate Analysis of Advinus Therapeutics Ltd

  • Figure Revenue and Market Share Analysis of Advinus Therapeutics Ltd

  • Table Product and Service Introduction of Advinus Therapeutics Ltd

  • Table Company Profile and Development Status of Arrien Pharmaceuticals, LLC

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrien Pharmaceuticals, LLC

  • Figure Sales and Growth Rate Analysis of Arrien Pharmaceuticals, LLC

  • Figure Revenue and Market Share Analysis of Arrien Pharmaceuticals, LLC

  • Table Product and Service Introduction of Arrien Pharmaceuticals, LLC

  • Table Company Profile and Development Status of Aurigene Discovery Technologies Limited

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurigene Discovery Technologies Limited

  • Figure Sales and Growth Rate Analysis of Aurigene Discovery Technologies Limited

  • Figure Revenue and Market Share Analysis of Aurigene Discovery Technologies Limited

  • Table Product and Service Introduction of Aurigene Discovery Technologies Limited

  • Table Company Profile and Development Status of Biogen, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen, Inc

  • Figure Sales and Growth Rate Analysis of Biogen, Inc

  • Figure Revenue and Market Share Analysis of Biogen, Inc

  • Table Product and Service Introduction of Biogen, Inc

  • Table Company Profile and Development Status of Brickell Biotech, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Brickell Biotech, Inc

  • Figure Sales and Growth Rate Analysis of Brickell Biotech, Inc

  • Figure Revenue and Market Share Analysis of Brickell Biotech, Inc

  • Table Product and Service Introduction of Brickell Biotech, Inc

  • Table Company Profile and Development Status of Bristol-Myers Squibb Company

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

  • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

  • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

  • Table Product and Service Introduction of Bristol-Myers Squibb Company

  • Table Company Profile and Development Status of Celgene Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

  • Figure Sales and Growth Rate Analysis of Celgene Corporation

  • Figure Revenue and Market Share Analysis of Celgene Corporation

  • Table Product and Service Introduction of Celgene Corporation

  • Table Company Profile and Development Status of Genentech, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc

  • Figure Sales and Growth Rate Analysis of Genentech, Inc

  • Figure Revenue and Market Share Analysis of Genentech, Inc

  • Table Product and Service Introduction of Genentech, Inc

  • Table Company Profile and Development Status of Genfit SA

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genfit SA

  • Figure Sales and Growth Rate Analysis of Genfit SA

  • Figure Revenue and Market Share Analysis of Genfit SA

  • Table Product and Service Introduction of Genfit SA

  • Table Company Profile and Development Status of GlaxoSmithKline Plc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

  • Table Product and Service Introduction of GlaxoSmithKline Plc

  • Table Company Profile and Development Status of Hanmi Pharmaceuticals, Co Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hanmi Pharmaceuticals, Co Ltd

  • Figure Sales and Growth Rate Analysis of Hanmi Pharmaceuticals, Co Ltd

  • Figure Revenue and Market Share Analysis of Hanmi Pharmaceuticals, Co Ltd

  • Table Product and Service Introduction of Hanmi Pharmaceuticals, Co Ltd

  • Table Company Profile and Development Status of Karo Bio AB

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Karo Bio AB

  • Figure Sales and Growth Rate Analysis of Karo Bio AB

  • Figure Revenue and Market Share Analysis of Karo Bio AB

  • Table Product and Service Introduction of Karo Bio AB

  • Table Company Profile and Development Status of Lead Pharma Holding BV

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lead Pharma Holding BV

  • Figure Sales and Growth Rate Analysis of Lead Pharma Holding BV

  • Figure Revenue and Market Share Analysis of Lead Pharma Holding BV

  • Table Product and Service Introduction of Lead Pharma Holding BV

  • Table Company Profile and Development Status of Nuevolution AB

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nuevolution AB

  • Figure Sales and Growth Rate Analysis of Nuevolution AB

  • Figure Revenue and Market Share Analysis of Nuevolution AB

  • Table Product and Service Introduction of Nuevolution AB

  • Table Company Profile and Development Status of Phenex Pharmaceuticals AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Phenex Pharmaceuticals AG

  • Figure Sales and Growth Rate Analysis of Phenex Pharmaceuticals AG

  • Figure Revenue and Market Share Analysis of Phenex Pharmaceuticals AG

  • Table Product and Service Introduction of Phenex Pharmaceuticals AG

  • Table Company Profile and Development Status of Reata Pharmaceuticals, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reata Pharmaceuticals, Inc

  • Figure Sales and Growth Rate Analysis of Reata Pharmaceuticals, Inc

  • Figure Revenue and Market Share Analysis of Reata Pharmaceuticals, Inc

  • Table Product and Service Introduction of Reata Pharmaceuticals, Inc

  • Table Company Profile and Development Status of Teijin Pharma Limited

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teijin Pharma Limited

  • Figure Sales and Growth Rate Analysis of Teijin Pharma Limited

  • Figure Revenue and Market Share Analysis of Teijin Pharma Limited

  • Table Product and Service Introduction of Teijin Pharma Limited

  • Table Company Profile and Development Status of Visionary Pharmaceuticals, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Visionary Pharmaceuticals, Inc

  • Figure Sales and Growth Rate Analysis of Visionary Pharmaceuticals, Inc

  • Figure Revenue and Market Share Analysis of Visionary Pharmaceuticals, Inc

  • Table Product and Service Introduction of Visionary Pharmaceuticals, Inc

  • Table Company Profile and Development Status of Vitae Pharmaceuticals, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vitae Pharmaceuticals, Inc

  • Figure Sales and Growth Rate Analysis of Vitae Pharmaceuticals, Inc

  • Figure Revenue and Market Share Analysis of Vitae Pharmaceuticals, Inc

  • Table Product and Service Introduction of Vitae Pharmaceuticals, Inc


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top